These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31355274)

  • 1. Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives.
    Trucchi C; Costantino C; Restivo V; Bertoncello C; Fortunato F; Tafuri S; Amicizia D; Martinelli D; Paganino C; Piazza MF; Tassinari F; Tisa V; Stefanizzi P; Baldo V; Casuccio A; Prato R; Ansaldi F; Icardi G
    Biomed Res Int; 2019; 2019():6764154. PubMed ID: 31355274
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions improving HPV vaccination uptake - Results from a national survey in Italy.
    Giambi C; Del Manso M; D'Ancona F; De Mei B; Giovannelli I; Cattaneo C; Possenti V; Declich S;
    Vaccine; 2015 May; 33(21):2425-31. PubMed ID: 25869895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015.
    Mroz S; Zhang X; Williams M; Conlon A; LoConte NK
    Prev Chronic Dis; 2017 Sep; 14():E85. PubMed ID: 28957034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
    Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.
    Machalek DA; Garland SM; Brotherton JML; Bateson D; McNamee K; Stewart M; Rachel Skinner S; Liu B; Cornall AM; Kaldor JM; Tabrizi SN
    J Infect Dis; 2018 Apr; 217(10):1590-1600. PubMed ID: 29425358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring reasons for non-vaccination against human papillomavirus in Italy.
    Giambi C; D'Ancona F; Del Manso M; De Mei B; Giovannelli I; Cattaneo C; Possenti V; Declich S;
    BMC Infect Dis; 2014 Nov; 14():545. PubMed ID: 25410754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the first HPV vaccination campaign in two northern Italian health districts.
    Chadenier GM; Colzani E; Faccini M; Borriello CR; Bonazzi C
    Vaccine; 2011 Jun; 29(26):4405-8. PubMed ID: 21501645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G; Baio G; Capone A; Marcellusi A; Saverio Mennini F
    Clin Ther; 2013 Jul; 35(7):904-14. PubMed ID: 23806328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
    Limia A; Pachón I
    Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
    Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
    Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
    Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].
    Sopracordevole F; Cigolot F; Lucia E; Marchesoni D
    Minerva Ginecol; 2009 Apr; 61(2):81-7. PubMed ID: 19255555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.
    Datta S; Pink J; Medley GF; Petrou S; Staniszewska S; Underwood M; Sonnenberg P; Keeling MJ
    BMC Infect Dis; 2019 Jun; 19(1):552. PubMed ID: 31234784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.